|
Susan M. Poutanen, Donald Low, and Allison McGeer
answer a
few questions about this month's fast breaking paper in the field of
Clinical Medicine.
From
•>>December 2003
Field:
Clinical Medicine
Article Title: Identification of severe acute respiratory syndrome in Canada
Authors: Poutanen,
SM;Low,
DE;Henry, B;Finkelstein, S;Rose, D;Green,
K;Tellier, R;Draker, R;Adachi, D;Ayers, M;Chan,
AK;Skowronski, DM;Salit, I;Simor, AE;Slutsky, AS;Doyle,
PW;Krajden, M;Petric, M;Brunham, RC;McGeer, AJ
Journal: N ENGL J MED
Volume: 348
Page: 1995-2005
Year: MAY 15 2003
* Toronto Med Labs, 600 Univ Ave, Rm 1460, Toronto, ON M5G 1X5, Canada.
* Toronto Med Labs, Toronto, ON M5G 1X5, Canada.
* Mt Sinai Hosp, Dept Microbiol, Toronto, ON M5G 1X5, Canada.
* Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.
* Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada.
* Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada.
* City Toronto Publ Hlth Dept, Toronto, ON, Canada.
* Scarborough Gen Hosp, Toronto, ON, Canada.
* Hosp Sick Children, Toronto, ON M5G 1X8, Canada.
* British Columbia Ctr Dis Control, Epidemiol Serv, Vancouver, BC, Canada.
* British Columbia Ctr Dis Control, Lab Serv, Vancouver, BC, Canada.
* Univ Hlth Network, Toronto, ON, Canada.
* Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada.
* St Michaels Hosp, Toronto, ON M5B 1W8, Canada.
* Vancouver Hosp & Hlth Sci Ctr, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada.
* Univ British Columbia, Ctr Dis Control, Vancouver, BC V5Z 1M9, Canada.
|
Why do you think your paper is highly cited?
This paper describes from a Canadian perspective a landmark
event in history which affected countries worldwide, namely the
global outbreak of the newly emerged infectious disease, Severe
Acute Respiratory Syndrome (SARS). The rapidity with which this
paper was written and with which the journal editors reviewed the
paper allowed for its early online release as one of the first
peer-reviewed papers on the topic of SARS. The timing of this
release coincided with the early stage of the worldwide SARS
outbreak during a time when the full extent of the outbreak was
still being learned and when very little was known about the
disease with regard to clinical and laboratory features, course of
the illness, and modes of transmission. The timeliness of this
publication, its free dissemination online, and the extremely
large baseline readership of the New England Journal of
Medicine, all enabled this paper to reach a very large captive
audience in a very short period of time. Indeed, this paper was
downloaded by more than 50,000 readers within only the first two
days of publication. In addition, it was translated into Chinese
and published in the China Medical Tribune, which is
distributed to more than 170,000 physicians in China. The target
audience of this paper includes persons from a wide range of
disciplines due to the paper’s inclusion of a wide range of data
regarding the identification of SARS in Canada relevant to fields
of epidemiology, clinical medicine, microbiology, and pathology.
The target audience of this paper continues to remain large given
concerns regarding the speed with which SARS spread worldwide when
it was first introduced and the uncertainty as to where and when
its potential re-emergence may occur.
Does it describe a new discovery or a new methodology that's
useful to others?
Yes. This paper describes a landmark event, specifically the
identification of SARS in Canada. It describes the initial
understanding of this newly discovered syndrome, enabling others
to learn from the experience of the paper’s authors.
Could you summarize the significance of your paper in layman's
terms?
This paper describes the identification of SARS in Canada from
the epidemiologic, clinical, microbiologic, and pathologic points
of view and was published in a timely manner enabling others to
learn from the experience of the paper’s authors in an
accelerated fashion while the SARS outbreak was indeed evolving.
Its initial description of the clinical syndrome and associated
pathology of SARS, the possible underlying cause(s) of SARS, and
the associated incubation period and likely mode of transmission
of SARS have since been corroborated by additional studies.
How did you become involved in this research?
Microbiologists, infectious disease physicians, public health
physicians, and infection control practitioners are inherently
called to be on the front lines against emerging infectious
diseases. As such, many of the authors have had prominent roles
working together during past outbreaks. When chance brought SARS
to Canada, it was a fortuitous opportunity for us to build on
previous collaborative relationships to work together to
understand and to share our understanding of SARS from the
Canadian perspective.
Susan M. Poutanen, MD, MPH, FRCPC
Post-doctoral Fellow
Department of Laboratory Medicine and Pathobiology (Medical Microbiology)
University of Toronto
and
Toronto Medical Laboratories & Mount Sinai Hospital
Toronto, Canada
Donald E. Low, MD, FRCPC
Professor
Department of Laboratory Medicine and Pathobiology (Medical Microbiology)
and
Department of Medicine (Infectious Diseases), University of Toronto
Microbiologist-in-Chief
Toronto Medical Laboratories & Mount Sinai Hospital
Toronto, Canada
Allison J. McGeer, MD, MSc, FRCPC
Professor
Department of Laboratory Medicine and Pathobiology (Medical Microbiology)
and
Department of Medicine (Infectious Diseases), University of Toronto
Director of Infection Control
Mount Sinai Hospital
Toronto, Canada
|
ESI Special Topics,
December 2003
Citing URL - http://www.esi-topics.com/fbp/2003/december03-Poutanen_Low_McGeer.html
|
|